PARSIPPANY, NJ--(Marketwired - December 01, 2014) - In need of a little extra cheer this holiday season?
CU Bancorp (NASDAQ: CUNB )
today announced that on November 30, 2014, it completed its previously
announced acquisition of 1 st Enterprise Bank (OTCQB:FENB)
through the merger of 1 st Enterprise Bank with and into
California United Bank, the wholly-owned subsidiary of CU Bancorp.
Baxter International Inc. (NYSE:BAX) today announced that the company
has submitted a biologics license application (BLA) to the United States
Food and Drug Administration (FDA) for the approval of BAX 855, an
investigational, extended half-life recombinant factor VIII (rFVIII)
treatment for hemophilia A based on ADVATE [Antihemophilic Factor
''The evidence from our late-stage controlled trial showcases that BAX
855 could become an important new treatment option for people with
hemophilia A, expanding on more than a decade of experience with
ADVATE,'' said John Orloff, M.D., vice president and global head of
research and development for Baxter BioScience.
LOS ANGELES,CA -- (Marketwired) -- 12/01/14 -- Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"), a patent licensing company, announced today that on November 27, 2014, its wholly owned subsidiary MedTech Development Deutschland GmbH took all necessary measures to start enforcement of an injunction against Stryker GmbH & Co.
Squibb Foundation today marked World AIDS Day by announcing 12 new
grants totaling $1.47 million that focus on strengthening
community-based services in sub-Saharan Africa for adolescents and the
elderly who are living with HIV and for HIV patients with comorbid
female cancers or tuberculosis.
Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, announced today the publication of a peer-reviewed article in
the Journal of the American Chemical Society describing the
discovery of GalNAc-conjugated siRNA as a novel strategy for delivery of
Tetra Tech, Inc. (NASDAQ: TTEK) announced today it has been awarded a
$216 million indefinite delivery indefinite quantity contract from the
U.S. Agency for International Development (USAID) to support the
implementation of USAID’s program, the Promoting Gender Equity in
National Priority Programs Project (PROMOTE) in Afghanistan.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.